Page last updated: 2024-08-16

timolol and Angioma

timolol has been researched along with Angioma in 79 studies

Research

Studies (79)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	57 (72.15)	24.3611
2020's	22 (27.85)	2.80

Authors

Authors	Studies
Hildebrand, GD; Sipkova, Z	1
Colmant, C; Powell, J	1
McLean, TW; Pahl, KS	1
Alcalá, R; Azaña Defez, JM; Azon, A; Bauzá, A; Bernabeu Wittel, J; Campos-Domínguez, M; Colmenero, M; Del Boz, J; Domínguez-Cruz, J; Feito-Rodríguez, M; García-Doval, I; Garnacho-Saucedo, G; Giacaman, A; González-Enseyat, MA; Grau-Pérez, M; Hernández-Martin, Á; Martín-Santiago, A; Monserrat García, MT; Palencia Pérez, SI; Roé, E; Sánchez Moya, AI; Tercedor-Sánchez, J; Torrelo, A; Valdivielso-Ramos, M; Vera Casaño, Á; Vicente-Villa, MA	1
Cai, Y; Chen, C; Gong, X; Kang, B; Li, W; Xu, Y; Yu, Q; Zheng, H	1
Cai, B; Chen, X; Huang, H; Wang, B; Yu, J	1
Gong, ZC; Li, CX; Li, H; Ling, B; Zhou, YC	1
Anwar, F; Jamgochian, M; Mahmood, E; Ouellette, S; Rao, B; Shah, R; Sharif, S; Umar, M	1
Lai, W; Luo, H; Zhu, H	1
Davis, RF; Paul, SP	1
Janmohamed, SR	1
Ballús, MM; Carreras, AC; Dotti-Boada, M; Izquierdo-Serra, J; Roca, MF; Sanchez-Tinajero, CV	1
Cao, Y; Li, L; Liu, D; Lv, X; Sun, L; Tian, L; Wang, C; Zhao, W	1
Duell, K; McNab, S	1
Abagge, KT; Mussato, LP; Oliveira de Carvalho, VO; Petterle, RR; Sakai, LSM; Sandri, CO	1
Chan, BHB; Cheng, JWCH; Chiu, WK; Fung, GPG; Lam, YY; Luk, DCK; Sin, C	1
Chang, L; Chang, S; Chen, Q; Chen, Z; Han, Y; Lin, X; Ma, G; Qiu, Y; Ying, H; Yu, Z	1
Dahle, SE; Gallegos, A; Isseroff, RR; Kaur, R; Schaefer, S; Tchanque-Fossuo, C; West, K; Yang, H; Yoon, DJ	1
Chang, L; Chang, SJ; Chen, QY; Chen, ZA; Lin, XX; Ma, G; Qiu, YJ; Ying, HR; Zhang, Y	1
Dodangeh, M; Goodarzi, A; Mozafarpoor, S; Seirafianpour, F; Shahverdi, MH	1
Lan, SJ; Liu, M; Liu, SS; Rong, L; Yang, TY; Zhang, JY	1
Dinarevic, SM; Kardasevic, M	1
Agrawal, S; Bajaj, MS; Das, D; Gupta, S; Modaboyina, S	1
He, L; Huang, G	1
Boyce, A; Flohr, C; Khan, M; Prieto-Merino, D; Svensson, Å; Wedgeworth, E	1
Foong, AYW; Koh, MJ; Ng, MSY; Ng, SS; Tay, YK	1
Bates, B; Drolet, BA; Keuter, T; Mueller, K; Schilter, K; Seefeldt, M; Yu, J	1
Guo, Y; Lei, S; Li, J; Long, J; Shi, Q; Wu, Q	1
Admani, S; Borok, J; Friedlander, SF; Gangar, P; Proudfoot, J	1
Dalla Costa, R; Prindaville, B; Wiss, K	1
Li, Y; Zheng, L	1
Huang, H; Li, W; Xu, P; Yu, Q; Zhang, W	1
Costa, RD; Prindaville, B; Rork, JF; Wiss, K	1
Drolet, BA; M Hill, I; Stefanko, N	1
Arevalo-Rodriguez, I; Baselga, E; Beltran, S; Giraldo, L; Novoa, M; Pardo-Hernandez, H; Shahbaz, A	1
La Placa, M; Neri, I; Piraccini, BM; Sacchelli, L; Vincenzi, C	1
Blei, F; Finkelstein, RA; Mody, K; Traube, C	1
Huang, AH; Lie, E; Mannschreck, DB; Psoter, K; Puttgen, K	1
Almebayadh, M	1
Li, L; Ma, L; Qiu, L; Wei, L; Zhang, B; Zhang, N	1
Antaya, RJ; Craiglow, BG	1
Chu, MB; Searcy, G; Siegfried, E	1
Chen, H; Hu, X; Jin, Y; Lin, X; Ma, G; Qiu, Y; Yang, J	1
Adams, S; Chan, H; McKay, C; Wargon, O	1
Karp, CL; Lee, RK; Lubahn, JG	1
Chang, TC; Estes, R	1
Cameán, M; Caracuel, F; Casas, M; Fernández-Anguita, MJ; Lucero, MJ; Merino-Bohórquez, V; Ramírez-Soto, G	1
Goelz, R; Poets, CF	1
Chung, HY; Jang, YH; Kim, DW; Lee, SJ; Lee, WJ; Park, KH	1
Fiorillo, L; Korownyk, C; Ross, D	1
La Placa, M; Neri, I; Patrizi, A; Virdi, A	1
Chang, L; Chen, H; Chen, M; Jin, Y; Lin, X; Ma, G; Qiu, Y; Wang, T; Yang, J	1
Cao, RY; Sun, NN; Tong, S; Wang, XK; Xu, DP; Xue, L	1
Garg, VK; Sarkar, R; Sethi, S	1
Cheng, C; Gong, H; Li, G; Li, YX; Wang, XK; Xu, DP	1
Li, G; Sun, NN; Tong, S; Wang, XK; Xu, DP; Xue, L	1
Chinnadurai, S; Fonnesbeck, C; Likis, FE; McPheeters, ML; Morad, A; Sathe, NA; Snyder, KM	1
Ge, J; Yuan, W; Zhang, L; Zhao, H; Zheng, J	1
Boos, MD; Castelo-Soccio, L	1
Baoli, S; Chunfen, L; Jiachuan, X; Linjun, Y; Qixing, X	1
Drolet, B; Frommelt, P; Holland, K; Juern, A; Seefeldt, M; Siegel, D; Uhing, M; Wade, K; Yu, J	1
Chang, CS; Kang, GC; Ng, ZY; Por, YC	1
Adams, D; Baselga, E; Drolet, B; Feigenbaum, D; Frieden, I; Garzon, MC; Holland, K; Horii, K; Lauren, C; Lucky, A; Mathes, E; McCuaig, C; Morel, KD; Newell, B; Nopper, A; Pope, E; Powell, J; Püttgen, K; Savva, Y; Siegel, D; Song, W	1
Cheng, CE; Friedlander, SF	1
Bly, RA; Parikh, SR; Perkins, J	1
Belloni Fortina, A; Causin, F; De Corti, F; Fontana, E	1
Chang, L; Gu, Y; Lin, X; Lyu, D; Ma, G; Qiu, Y; Ying, H; Yu, W; Zou, Y	1
Fan, XD; Huo, R; Jiang, CH; Lei, SR; Liu, SH; Qin, ZP; Wang, XK; Wang, XY; Yang, YW; Zhao, JH; Zheng, JW; Zhou, DK	1
Chakkittakandiyil, A; Pope, E	1
Khunger, N; Pahwa, M	1
Blatt, J; Buck, S; Burkhart, CN; Gold, S; Morrell, DS; Powell, C; Stavas, J; Zdanski, C	1
Krol, A; Lofgren, S	1
Gonzalez, ME; Orlow, SJ; Tlougan, BE	1
de Laat, PC; Janmohamed, SR; Madern, GC; Oranje, AP	1
Cante, V; Ezzedine, K; Imbert, E; Léauté-Labrèze, C; Pham-Ledard, A	1
Escudero-Gómez, J; Fernández-Ballesteros, MD; Hiraldo-Gamero, A; Vera-Casaño, A	1
Kazandjieva, J; Semkova, K	1
Frieden, IJ; Tollefson, MM	1
Chen, H; Chen, XD; Hu, XJ; Jin, YB; Lin, XX; Ma, G; Qiu, YJ; Ye, XX	1

Reviews

18 review(s) available for timolol and Angioma

Article	Year
Medical Management of Infantile Hemangiomas: An Update. Paediatric drugs, 2022, Volume: 24, Issue:1 Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Hemangioma; Humans; Infant; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome	2022
Infantile Hemangioma: A Current Review. Journal of pediatric hematology/oncology, 2022, 03-01, Volume: 44, Issue:2 Topics: Adrenergic beta-Antagonists; Child; Hemangioma; Humans; Infant; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome	2022
Comparison of the efficacy and safety of lasers, topical timolol, and combination therapy for the treatment of infantile hemangioma: A meta-analysis of 10 studies. Dermatologic therapy, 2022, Volume: 35, Issue:12 Topics: Administration, Topical; Adrenergic beta-Antagonists; Combined Modality Therapy; Hemangioma; Humans; Infant; Lasers; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome	2022
Repurposing Ophthalmologic Timolol for Dermatologic Use: Caveats and Historical Review of Adverse Events. American journal of clinical dermatology, 2021, Volume: 22, Issue:1 Topics: Absorption, Physiological; Administration, Cutaneous; Adrenergic beta-Antagonists; Cardiovascular Diseases; Drug Repositioning; Hemangioma; History, 20th Century; Humans; Ophthalmic Solutions; Respiration Disorders; Skin; Timolol	2021
The role of topical timolol in wound healing and the treatment of vascular lesions: A narrative review. Dermatologic therapy, 2021, Volume: 34, Issue:2 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma; Humans; Keratinocytes; Timolol; Wound Healing	2021
The Role of Topical Timolol in the Treatment of Infantile Hemangiomas: A Systematic Review and Meta-analysis. Acta dermato-venereologica, 2017, Nov-15, Volume: 97, Issue:10 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Age of Onset; Antineoplastic Agents; Hemangioma; Humans; Infant; Infant, Newborn; Odds Ratio; Risk Factors; Time Factors; Timolol; Treatment Outcome; Tumor Burden	2017
Effect of topical timolol on response rate and adverse events in infantile hemangioma: a meta-analysis. Archives of dermatological research, 2018, Volume: 310, Issue:4 Topics: Administration, Topical; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Hemangioma; Humans; Infant, Newborn; Infant, Newborn, Diseases; Placebo Effect; Propranolol; Timolol	2018
Interventions for infantile haemangiomas of the skin: abridged Cochrane systematic review and GRADE assessments. The British journal of dermatology, 2019, Volume: 180, Issue:3 Topics: Administration, Cutaneous; Administration, Oral; Adrenergic beta-Antagonists; Bradycardia; GRADE Approach; Hemangioma; Humans; Hypotension; Placebos; Propranolol; Randomized Controlled Trials as Topic; Skin Neoplasms; Timolol	2019
Successful treatment of ulcerated infantile hemangioma with brimonidine-timolol cream: 2 cases report and review of the literature. The Journal of dermatological treatment, 2020, Volume: 31, Issue:4 Topics: Administration, Topical; Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-Antagonists; Brimonidine Tartrate; Drug Combinations; Female; Hemangioma; Humans; Infant; Ointments; Skin Neoplasms; Skin Ulcer; Timolol	2020
Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches. Paediatric drugs, 2013, Volume: 15, Issue:2 Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Aminoquinolines; Hemangioma; Humans; Imiquimod; Infant; Off-Label Use; Propranolol; Skin Neoplasms; Timolol	2013
Resolution of conjunctival sessile hemangioma with topical timolol. Cornea, 2014, Volume: 33, Issue:1 Topics: Adrenergic beta-Antagonists; Aged; Antineoplastic Agents; Conjunctival Neoplasms; Female; Hemangioma; Humans; Ophthalmic Solutions; Timolol; Treatment Outcome	2014
Incidence and treatment of infantile haemangioma in preterm infants. Archives of disease in childhood. Fetal and neonatal edition, 2015, Volume: 100, Issue:1 Topics: Adrenergic beta-Antagonists; Cryotherapy; Hemangioma; Humans; Incidence; Infant, Premature; Infant, Premature, Diseases; Propranolol; Timolol; Treatment Outcome	2015
Novel treatment for infantile hemangiomas. Canadian family physician Medecin de famille canadien, 2014, Volume: 60, Issue:12 Topics: Adrenergic beta-Antagonists; Hemangioma; Humans; Infant; Infant, Newborn; Propranolol; Timolol	2014
Pharmacologic Interventions for Infantile Hemangioma: A Meta-analysis. Pediatrics, 2016, Volume: 137, Issue:2 Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Glucocorticoids; Hemangioma; Humans; Infant; Infant, Newborn; Propranolol; Timolol	2016
Efficacy of Topical Timolol as Primary Monotherapy in Cutaneous Facial Infantile Hemangiomas. The Journal of craniofacial surgery, 2016, Volume: 27, Issue:6 Topics: Administration, Topical; Adrenergic beta-Antagonists; Child; Facial Neoplasms; Hemangioma; Humans; Timolol; Treatment Outcome	2016
Infantile hemangiomas, complications and treatments. Seminars in cutaneous medicine and surgery, 2016, Volume: 35, Issue:3 Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Airway Obstruction; Drug Therapy, Combination; Esthetics; Facial Neoplasms; Hemangioma; Humans; Infant; Laser Therapy; Propranolol; Skin Neoplasms; Skin Ulcer; Timolol	2016
Can topical beta-blockers reduce the size of superficial infantile hemangiomas of the head and neck? The Laryngoscope, 2017, Volume: 127, Issue:1 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma; Humans; Practice Guidelines as Topic; Skin Neoplasms; Timolol	2017
New therapies in pediatric dermatology. Current opinion in pediatrics, 2011, Volume: 23, Issue:4 Topics: Adrenergic beta-Antagonists; Child; Dermatitis, Atopic; Epidermolysis Bullosa Dystrophica; Etanercept; Hemangioma; Humans; Immunoglobulin G; Immunosuppressive Agents; Pediatrics; Psoriasis; Receptors, Tumor Necrosis Factor; Skin Diseases; Skin Neoplasms; Tacrolimus; Timolol; Ultraviolet Therapy; Vitamin D; Vitamins	2011

Trials

7 trial(s) available for timolol and Angioma

Article	Year
Randomised controlled trial: Can topical timolol maleate prevent complications for small superficial infantile haemangiomata in high-risk areas? Pediatric research, 2020, Volume: 88, Issue:5 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Antineoplastic Agents; Female; Hemangioma; Hong Kong; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Time Factors; Timolol; Treatment Outcome; Tumor Burden	2020
The effect of 0.5% topical timolol cream on regression of superficial infantile haemangioma in the involuting phase: a prospective, randomized, self-controlled study. European journal of dermatology : EJD, 2020, Oct-01, Volume: 30, Issue:5 Topics: Antineoplastic Agents; Child, Preschool; Dermatologic Agents; Female; Hemangioma; Humans; Infant; Male; Prospective Studies; Skin Cream; Skin Neoplasms; Timolol; Treatment Outcome	2020
Comparison of the efficacy between topical timolol and pulsed dye laser in the treatment of ulcerated infantile haemangiomas: a randomized controlled study. Journal of the European Academy of Dermatology and Venereology : JEADV, 2021, Volume: 35, Issue:4 Topics: Administration, Topical; Hemangioma; Hemangioma, Capillary; Humans; Infant; Lasers, Dye; Skin Neoplasms; Timolol; Treatment Outcome; Ulcer	2021
Safety and efficacy of topical timolol treatment of infantile haemangioma: a prospective trial. The British journal of dermatology, 2018, Volume: 178, Issue:1 Topics: Administration, Topical; Antineoplastic Agents; Drug Administration Schedule; Facial Neoplasms; Female; Head and Neck Neoplasms; Hemangioma; Humans; Infant; Male; Prospective Studies; Scalp; Skin Neoplasms; Timolol; Treatment Outcome	2018
RCT of timolol maleate gel for superficial infantile hemangiomas in 5- to 24-week-olds. Pediatrics, 2013, Volume: 131, Issue:6 Topics: Double-Blind Method; Female; Gels; Hemangioma; Humans; Infant; Male; Skin Neoplasms; Timolol; Treatment Outcome	2013
Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions. The Journal of craniofacial surgery, 2016, Volume: 27, Issue:1 Topics: Administration, Oral; Administration, Topical; Antineoplastic Agents; Drug Therapy, Combination; Facial Neoplasms; Female; Follow-Up Studies; Hemangioma; Humans; Infant; Male; Mouth Neoplasms; Propranolol; Prospective Studies; Safety; Skin Neoplasms; Timolol; Treatment Outcome; Ultrasonography; Visual Analog Scale	2016
Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study. Scientific reports, 2016, Jan-28, Volume: 6 Topics: Administration, Oral; Administration, Topical; Aftercare; Female; Hemangioma; Humans; Infant; Infant, Newborn; Male; Propranolol; Retrospective Studies; Skin Neoplasms; Time Factors; Timolol	2016

Other Studies

54 other study(ies) available for timolol and Angioma

Article	Year
Topical Timolol for Infantile Haemangioma of the Orbit. Klinische Monatsblatter fur Augenheilkunde, 2021, Volume: 238, Issue:10 Topics: Hemangioma; Humans; Infant; Neoplasm Recurrence, Local; Orbit; Timolol; Treatment Outcome	2021
Inter- and intra-observer variability in the selection of therapy for infantile hemangiomas among pediatric dermatologists in Spain. Pediatric dermatology, 2022, Volume: 39, Issue:4 Topics: Child; Cross-Sectional Studies; Dermatologists; Hemangioma; Hemangioma, Capillary; Humans; Observer Variation; Pediatrics; Propranolol; Spain; Timolol	2022
Predictors of treatment responses of superficial infantile hemangiomas to topical timolol. Dermatologic therapy, 2022, Volume: 35, Issue:11 Topics: Administration, Topical; Adrenergic beta-Antagonists; Child, Preschool; Hemangioma; Humans; Infant; Prospective Studies; Skin Neoplasms; Timolol; Treatment Outcome	2022
Application of topical betaxolol to cure superficial infantile hemangioma: A pilot study. Pediatrics international : official journal of the Japan Pediatric Society, 2022, Volume: 64, Issue:1 Topics: Adrenergic beta-Antagonists; Betaxolol; Child; Hemangioma; Hemangioma, Capillary; Humans; Infant; Pilot Projects; Skin Neoplasms; Timolol; Treatment Outcome	2022
Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangiomas. Journal of drugs in dermatology : JDD, 2023, Jun-01, Volume: 22, Issue:6 Topics: Administration, Topical; Female; Hemangioma; Humans; Hydrogels; Infant; Infant, Newborn; Male; Timolol; Treatment Outcome	2023
Efficacy of timolol in the treatment of facial hemangioma and its effect on the proliferation and apoptosis of hemangioma stem cells. Cellular and molecular biology (Noisy-le-Grand, France), 2023, Oct-31, Volume: 69, Issue:10 Topics: Cell Proliferation; Child; Hemangioma; Humans; Infant; Skin Neoplasms; Timolol; Treatment Outcome	2023
Infantile haemangioma: topical timolol gel may be safer in premature babies. British journal of hospital medicine (London, England : 2005), 2019, Aug-02, Volume: 80, Issue:8 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma; Humans; Infant, Newborn; Infant, Premature, Diseases; Skin Neoplasms; Timolol	2019
Comment on "Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas". Pediatric dermatology, 2019, Volume: 36, Issue:5 Topics: Hemangioma; Hemangioma, Capillary; Humans; Propranolol; Timolol	2019
Iris hemangioma of the newborn: Regression after topical timolol. Journal francais d'ophtalmologie, 2020, Volume: 43, Issue:2 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma; Humans; Infant, Newborn; Infant, Newborn, Diseases; Iris Neoplasms; Male; Remission Induction; Timolol; Tomography, Optical Coherence	2020
Fractional 2940-nm Er:YAG laser-assisted drug delivery of timolol maleate for the treatment of deep infantile hemangioma. The Journal of dermatological treatment, 2021, Volume: 32, Issue:8 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma; Humans; Infant; Lasers, Solid-State; Pharmaceutical Preparations; Skin Neoplasms; Timolol; Treatment Outcome	2021
Propranolol and topical timolol for infantile haemangiomas of the skin. Journal of paediatrics and child health, 2020, Volume: 56, Issue:3 Topics: Hemangioma; Hemangioma, Capillary; Humans; Propranolol; Skin; Timolol	2020
Colorimetric analysis of images in the follow-up of infantile hemangiomas. Pediatric dermatology, 2020, Volume: 37, Issue:4 Topics: Adrenergic beta-Antagonists; Colorimetry; Female; Follow-Up Studies; Hemangioma; Hemangioma, Capillary; Humans; Infant; Skin Neoplasms; Timolol; Treatment Outcome	2020
Topical Timolol Combined Intralesional Injection of Diprospan in the Treatment of Elevated Localized Mixed Infantile Hemangiomas and a Discussion for Proper Timing for Injection. The Journal of craniofacial surgery, 2021, May-01, Volume: 32, Issue:3 Topics: Administration, Topical; Adrenergic beta-Antagonists; Betamethasone; Drug Combinations; Hemangioma; Humans; Infant; Injections, Intralesional; Skin Neoplasms; Timolol; Treatment Outcome	2021
Infantile Sacral Region Hemangioma and Combination Treatment with Propranolol and Topical Timolol: Case Review and Reference Review. Medical archives (Sarajevo, Bosnia and Herzegovina), 2021, Volume: 75, Issue:2 Topics: Administration, Topical; Adrenergic beta-Antagonists; Bosnia and Herzegovina; Female; Hemangioma; Humans; Infant; Propranolol; Sacrococcygeal Region; Timolol; Treatment Outcome; Vasodilator Agents	2021
Effectiveness of treatment of acquired capillary haemangioma using timolol. Clinical & experimental optometry, 2022, Volume: 105, Issue:5 Topics: Hemangioma; Hemangioma, Capillary; Humans; Timolol	2022
Spectral Doppler ultrasound for predicting long-term response to topical timolol in children with infantile hemangioma. Journal of clinical ultrasound : JCU, 2017, Volume: 45, Issue:8 Topics: Administration, Topical; Adrenergic beta-Antagonists; Female; Follow-Up Studies; Hemangioma; Humans; Infant; Infant, Newborn; Male; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Timolol; Treatment Outcome; Ultrasonography, Doppler	2017
Comparison of Two Formulations of Topical Timolol for the Treatment of Infantile Hemangiomas. Pediatric dermatology, 2017, Volume: 34, Issue:4 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma; Humans; Infant; Ophthalmic Solutions; Retrospective Studies; Skin Neoplasms; Timolol; Treatment Outcome	2017
Variability of Delivery of Timolol for the Treatment of Infantile Hemangiomas. Pediatric dermatology, 2017, Volume: 34, Issue:4 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma; Humans; Pharmaceutical Solutions; Skin Neoplasms; Timolol	2017
[Usage and efficacy of timolol maleate eye drops in treatment of superficial infantile hemangioma]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2017, Jun-28, Volume: 42, Issue:6 Topics: Administration, Topical; Drug Administration Schedule; Eye Neoplasms; Hemangioma; Humans; Infant; Ophthalmic Solutions; Timolol; Treatment Outcome	2017
Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas. Pediatric dermatology, 2018, Volume: 35, Issue:2 Topics: Administration, Topical; Adrenergic beta-Antagonists; Dose-Response Relationship, Drug; Drug Dosage Calculations; Hemangioma; Humans; Infant; Maximum Tolerated Dose; Timolol	2018
A self-controlled study of intralesional injection of diprospan combined with topical timolol cream for treatment of thick superficial infantile hemangiomas. Dermatologic therapy, 2018, Volume: 31, Issue:3 Topics: Administration, Topical; Betamethasone; Drug Combinations; Hemangioma; Humans; Infant; Injections, Intralesional; Ointments; Timolol	2018
Response to "Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas". Pediatric dermatology, 2018, Volume: 35, Issue:5 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma; Hemangioma, Capillary; Humans; Infant; Skin Neoplasms; Timolol; Treatment Outcome	2018
Comment on "Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas". Pediatric dermatology, 2018, Volume: 35, Issue:5 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma; Hemangioma, Capillary; Humans; Infant; Skin Neoplasms; Timolol; Treatment Outcome	2018
Allergic contact dermatitis caused by timolol eyedrop application for infantile haemangioma. Contact dermatitis, 2019, Volume: 80, Issue:4 Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Dermatitis, Allergic Contact; Eczema; Emollients; Female; Glucocorticoids; Hemangioma; Humans; Infant; Italy; Male; Methylprednisolone; Ophthalmic Solutions; Patch Tests; Skin Cream; Timolol; Treatment Outcome	2019
More Than Skin Deep: Lethargy and Diaphoresis in the Morning. Pediatric emergency care, 2018, Volume: 34, Issue:12 Topics: Adrenergic beta-Antagonists; Diagnosis, Differential; Female; Hemangioma; Humans; Infant; Lethargy; Skin; Sweating; Timolol	2018
Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas. Pediatric dermatology, 2019, Volume: 36, Issue:3 Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Combined Modality Therapy; Drug Administration Schedule; Female; Hemangioma; Humans; Infant; Male; Propranolol; Retrospective Studies; Timolol; Treatment Outcome	2019
Topical timolol maleate for treatment of tufted angioma. The Journal of dermatology, 2019, Volume: 46, Issue:11 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Biopsy; Child, Preschool; Female; Hemangioma; Humans; Ophthalmic Solutions; Skin; Skin Neoplasms; Timolol; Treatment Outcome	2019
Efficacy of topical brimonidine-timolol for haemangioma of infancy and perils of off-label prescribing. BMJ case reports, 2013, Apr-17, Volume: 2013 Topics: Brimonidine Tartrate, Timolol Maleate Drug Combination; Drug Combinations; Female; Hemangioma; Humans; Infant; Male; Off-Label Use; Quinoxalines; Timolol	2013
Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study. Clinical and experimental dermatology, 2013, Volume: 38, Issue:8 Topics: Administration, Topical; Adrenergic beta-Antagonists; Aminoquinolines; Antineoplastic Agents; Female; Hemangioma; Humans; Imiquimod; Infant; Male; Retrospective Studies; Skin Neoplasms; Timolol	2013
Beta blocker treatment of infantile conjunctival hemangiomas--observations from 2 cases. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2014, Volume: 18, Issue:1 Topics: Adrenergic beta-Antagonists; Conjunctival Neoplasms; Female; Hemangioma; Humans; Infant; Propranolol; Timolol	2014
Physicochemical stability of a new topical timolol 0.5% gel formulation for the treatment of infant hemangioma. Pharmaceutical development and technology, 2015, Volume: 20, Issue:5 Topics: Administration, Topical; Adrenergic beta-Antagonists; Antihypertensive Agents; Chromatography, High Pressure Liquid; Drug Stability; Drug Storage; Gels; Hemangioma; Humans; Infant; Rheology; Timolol	2015
Topical timolol maleate 0.5% for infantile hemangioma; it's effectiveness and/or adjunctive pulsed dye laser - single center experience of 102 cases in Korea. The Journal of dermatological treatment, 2015, Volume: 26, Issue:4 Topics: Adrenergic beta-Antagonists; Combined Modality Therapy; Female; Hemangioma; Humans; Infant; Lasers, Dye; Male; Republic of Korea; Retrospective Studies; Skin Neoplasms; Timolol; Treatment Outcome	2015
A perineal infantile haemangioma presenting as early ulcerations. Archives of disease in childhood. Fetal and neonatal edition, 2015, Volume: 100, Issue:5 Topics: Bandages, Hydrocolloid; Female; Hemangioma; Humans; Infant, Newborn; Perineum; Skin Neoplasms; Skin Ulcer; Timolol	2015
A prospective self-controlled study of topical timolol 0.5% cream for large superficial infantile hemangiomas. The Journal of dermatology, 2015, Volume: 42, Issue:4 Topics: Administration, Topical; Adrenergic beta-Antagonists; Female; Hemangioma; Humans; Infant; Male; Prospective Studies; Skin Cream; Skin Neoplasms; Timolol	2015
Topical timolol maleate for superficial infantile hemangiomas: an observational study. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2015, Volume: 73, Issue:6 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Blood Glucose; Blood Pressure; Female; Follow-Up Studies; Head and Neck Neoplasms; Heart Rate; Hemangioma; Humans; Infant; Male; Photography; Remission Induction; Safety; Skin Neoplasms; Timolol; Treatment Outcome	2015
Topical timolol in nasal tip hemangioma: a viable alternative to systemic therapy. International journal of dermatology, 2015, Volume: 54, Issue:6 Topics: Administration, Topical; Female; Hemangioma; Humans; Infant; Nose Neoplasms; Skin Neoplasms; Timolol	2015
Evaluation of the efficacy and safety of propranolol, timolol maleate, and the combination of the two, in the treatment of superficial infantile haemangiomas. The British journal of oral & maxillofacial surgery, 2015, Volume: 53, Issue:9 Topics: Adrenergic beta-Antagonists; Drug Combinations; Hemangioma; Humans; Propranolol; Prospective Studies; Skin Neoplasms; Timolol; Treatment Outcome	2015
Experience with topical timolol maleate for the treatment of ulcerated infantile hemangiomas (IH). Journal of the American Academy of Dermatology, 2016, Volume: 74, Issue:3 Topics: Administration, Topical; Female; Gels; Hemangioma; Humans; Infant; Male; Retrospective Studies; Skin Neoplasms; Skin Ulcer; Timolol	2016
[A clinical study of Timolol Maleate Eye Drops for the treatment of superficial infantile hemangiomas]. Zhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery, 2015, Volume: 31, Issue:6 Topics: Administration, Topical; Adrenergic beta-Antagonists; Child; Hemangioma; Humans; Ophthalmic Solutions; Skin Neoplasms; Timolol; Treatment Outcome; Watchful Waiting	2015
Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma. Pediatric dermatology, 2016, Volume: 33, Issue:4 Topics: Adrenergic beta-Antagonists; Blood Pressure; Bradycardia; Electrocardiography, Ambulatory; Heart Rate; Hemangioma; Humans; Infant; Infant, Newborn; Infant, Premature; Retrospective Studies; Timolol; Treatment Outcome	2016
Topical Timolol Maleate Treatment of Infantile Hemangiomas. Pediatrics, 2016, Volume: 138, Issue:3 Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Cohort Studies; Female; Hemangioma; Humans; Infant; Infant, Newborn; Male; Off-Label Use; Propranolol; Retrospective Studies; Skin Neoplasms; Timolol; Visual Analog Scale	2016
Phace syndrome: is timolol gel a chance for treatment? Journal of the European Academy of Dermatology and Venereology : JEADV, 2017, Volume: 31, Issue:7 Topics: Abnormalities, Multiple; Administration, Topical; Arteries; Brain; Cranial Fossa, Posterior; Eye Abnormalities; Gels; Heart Defects, Congenital; Hemangioma; Humans; Infant; Phenotype; Skin Neoplasms; Syndrome; Timolol	2017
Prospective, open-label, rater-blinded and self-controlled pilot study of the treatment of proliferating superficial infantile hemangiomas with 0.5% topical timolol cream versus 595-nm pulsed dye laser. The Journal of dermatology, 2017, Volume: 44, Issue:6 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Female; Hemangioma; Humans; Infant; Lasers, Dye; Low-Level Light Therapy; Male; Pilot Projects; Prospective Studies; Timolol	2017
[Chinese expert consensus on the use of topical timolol maleate treatment of infantile hemangiomas]. Shanghai kou qiang yi xue = Shanghai journal of stomatology, 2016, Volume: 25, Issue:6 Topics: Administration, Topical; Adrenergic beta-Antagonists; Asian People; Consensus; Expert Testimony; Hemangioma; Humans; Infant; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome	2016
Topical timolol gel for infantile hemangiomas: a pilot study. Archives of dermatology, 2010, Volume: 146, Issue:5 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Child, Preschool; Female; Gels; Head and Neck Neoplasms; Hemangioma; Humans; Infant; Male; Pilot Projects; Retrospective Studies; Timolol; Treatment Outcome	2010
Dramatic response to topical timolol lotion of a large hemifacial infantile haemangioma associated with PHACE syndrome. The British journal of dermatology, 2011, Volume: 164, Issue:4 Topics: Abnormalities, Multiple; Administration, Topical; Adrenergic beta-Agonists; Facial Neoplasms; Female; Hemangioma; Humans; Infant; Magnetic Resonance Imaging; Syndrome; Timolol; Treatment Outcome	2011
β-blockers for infantile hemangiomas: a single-institution experience. Clinical pediatrics, 2011, Volume: 50, Issue:8 Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Drug Monitoring; Female; Head and Neck Neoplasms; Hemangioma; Humans; Infant; Laryngeal Neoplasms; Liver Neoplasms; Male; Propranolol; Retrospective Studies; Timolol	2011
Abortive segmental perineal hemangioma. Dermatology online journal, 2011, Oct-15, Volume: 17, Issue:10 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Biomarkers, Tumor; Female; Glucose Transporter Type 1; Hemangioma; Humans; Infant; Perineum; Skin Neoplasms; Skin Ulcer; Timolol	2011
Treatment of small superficial haemangioma with timolol 0.5% ophthalmic solution: a series of 20 cases. Dermatology (Basel, Switzerland), 2011, Volume: 223, Issue:4 Topics: Administration, Topical; Female; Hemangioma; Humans; Infant; Male; Ophthalmic Solutions; Timolol	2011
First report of topical timolol treatment in primarily ulcerated perineal haemangioma. Archives of disease in childhood. Fetal and neonatal edition, 2012, Volume: 97, Issue:2 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Female; Hemangioma; Humans; Infant, Newborn; Male; Perineum; Skin Ulcer; Timolol	2012
[Infantile hemangioma of the eyelid treated with timolol gel]. Actas dermo-sifiliograficas, 2012, Volume: 103, Issue:5 Topics: Eyelid Neoplasms; Female; Gels; Hemangioma; Humans; Infant; Timolol	2012
Topical timolol maleate for treatment of infantile haemangiomas: preliminary results of a prospective study. Clinical and experimental dermatology, 2013, Volume: 38, Issue:2 Topics: Adrenergic beta-Antagonists; Child, Preschool; Female; Hemangioma; Humans; Infant; Male; Prospective Studies; Timolol	2013
Early growth of infantile hemangiomas: what parents' photographs tell us. Pediatrics, 2012, Volume: 130, Issue:2 Topics: Adrenal Cortex Hormones; Age Factors; Diseases in Twins; Facial Neoplasms; Female; Hemangioma; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Lasers, Dye; Male; Nonlinear Dynamics; Photography; Propranolol; Referral and Consultation; Skin; Skin Neoplasms; Timolol; Treatment Outcome	2012
[Topical timolol in the treatment of periocular superficial infantile hemangiomas: a prospective study]. Zhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery, 2012, Volume: 28, Issue:3 Topics: Administration, Topical; Angiogenesis Inhibitors; China; Facial Neoplasms; Hemangioma; Hemangioma, Capillary; Humans; Infant; Prospective Studies; Skin Neoplasms; Timolol; Treatment Outcome	2012